145 related articles for article (PubMed ID: 11030527)
1. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes.
Nomura S; Okamae F; Abe M; Hosokawa M; Yamaoka M; Ohtani T; Onishi S; Matsuzaki T; Teraoka A; Ishida T; Fukuhara S
Clin Appl Thromb Hemost; 2000 Oct; 6(4):213-21. PubMed ID: 11030527
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow.
Forlow SB; McEver RP; Nollert MU
Blood; 2000 Feb; 95(4):1317-23. PubMed ID: 10666205
[TBL] [Abstract][Full Text] [Related]
3. Interaction of leukocytes with platelet microparticles derived from outdated platelet concentrates.
Miyamoto S; Kowalska MA; Marcinkiewicz C; Marcinkiewicz MM; Mosser D; Edmunds LH; Niewiarowski S
Thromb Haemost; 1998 Dec; 80(6):982-8. PubMed ID: 9869171
[TBL] [Abstract][Full Text] [Related]
4. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo.
Frenette PS; Denis CV; Weiss L; Jurk K; Subbarao S; Kehrel B; Hartwig JH; Vestweber D; Wagner DD
J Exp Med; 2000 Apr; 191(8):1413-22. PubMed ID: 10770806
[TBL] [Abstract][Full Text] [Related]
5. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
6. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
[TBL] [Abstract][Full Text] [Related]
7. Platelet microparticles and soluble P selectin in peripheral artery disease: relationship to extent of disease and platelet activation markers.
Tan KT; Tayebjee MH; Lynd C; Blann AD; Lip GY
Ann Med; 2005; 37(1):61-6. PubMed ID: 15902848
[TBL] [Abstract][Full Text] [Related]
8. PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets.
Dole VS; Bergmeier W; Patten IS; Hirahashi J; Mayadas TN; Wagner DD
Thromb Haemost; 2007 Oct; 98(4):806-12. PubMed ID: 17938805
[TBL] [Abstract][Full Text] [Related]
9. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
[TBL] [Abstract][Full Text] [Related]
10. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
[TBL] [Abstract][Full Text] [Related]
11. A 28-kDa glycoprotein functions as a platelet ligand for P-selectin (CD62P).
Li L; Qian KX; Geng JG
Thromb Haemost; 2002 Apr; 87(4):706-11. PubMed ID: 12008955
[TBL] [Abstract][Full Text] [Related]
12. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.
Choudhury A; Chung I; Blann AD; Lip GYH
Chest; 2007 Mar; 131(3):809-815. PubMed ID: 17356097
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
[TBL] [Abstract][Full Text] [Related]
14. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
Klüter H; Bubel S; Kirchner H; Wilhelm D
Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
[TBL] [Abstract][Full Text] [Related]
15. P-selectin expression on platelets determines size and stability of platelet aggregates.
Merten M; Thiagarajan P
Circulation; 2000 Oct; 102(16):1931-6. PubMed ID: 11034941
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of platelet activation in leukocyte-depleted platelet concentrates during storage.
Vucic M; Stanojkovic Z; Antic A; Vucic J; Pavlovic V
Bosn J Basic Med Sci; 2018 Feb; 18(1):29-34. PubMed ID: 28926321
[TBL] [Abstract][Full Text] [Related]
17. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
[TBL] [Abstract][Full Text] [Related]
18. Binding of activated platelets to WBCs in vivo after transfusion.
Gutensohn K; Geidel K; Brockmann M; Siemensen M; Krueger W; Kroeger N; Kuehnl P
Transfusion; 2002 Oct; 42(10):1373-80. PubMed ID: 12423523
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
Trial to Reduce Alloimmunization to Platelets Study Group
N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
